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Germinal centers are discrete sites of lymphoid blastogenesis that arise within the 
follicles of lymphoid organs in response to antigenic stimulation. They consist predom- 
inantly of dividing B cells (1), but also contain interspersed macrophages and antigen- 
presenting follicular dendritic cells  (2,  3), as well as small numbers of T  cells (4)  of 
helper  (Lyt-l+,2  -)  phenotype  (5).  The differentiation pathway(s)  and the nature of 
the B lymphoblasts in germinal centers have been a  mystery due to the absence of a 
specific cell surface marker that would allow their study in cell suspensions. However, 
such a  marker for germinal center lymphoid cells (GCLC) 1 has recently been identi- 
fied: Peanut agglutinin  (PNA), a  plant lectin with specificity for terminal galactosyl 
residues  on  cell  surface  oligosaccharides,  binds  selectively  to  GCLC  in  antigen- 
stimulated mouse lymphoid organs  (1, 6,  7).  Hence, GCLC can be identified in cell 
suspensions as a  distinct  "PNA  hi'' B  cell  population,  binding  10-30  times as much 
PNA as other B cells and most T  cells, which are therefore designated "PNA  l°'' (1, 7). 
Most plasma cells and plasmablasts are also PNA  I° (1,  7). 
We have recently used PNA in conjunction with other markers to study the surface 
phenotype  of  GCLC  (1).  Peyer's  patch  (PP)  GCLC  bear  low  levels  of  surface 
immunoglobulin  (Ig), with  IgA being the  major isotype expressed  (1).  The surface 
IgA  +, IgM-, IgD- phenotype of most GCLC in this site is strikingly different from the 
IgA-, IgM  +, IgD  + phenotype of the smaller PNA  l° PP B cells, but perhaps more than 
coincidentally similar to that characterizing IgA plasma cell precursors as studied in 
rabbit PP (8) and rat thoracic duct lymph (9). GCLC in immunized peripheral lymph 
nodes are also IgD- (7), and are thought  to contain progenitors of IgG plasma cells 
(7,  10,  11). Germinal centers in these nodes can be induced with specified antigens, 
allowing  us  to  better  characterize  the  responses  taking  place  within  the  germinal 
center. Our studies, consistent with earlier investigations (12), have shown that many 
GCLC are specific for the immunizing antigen  (7).  In addition,  we have presented 
evidence suggesting that GCLC undergo antigen-driven differentiation  (specifically, 
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heavy chain class switching upon  reexposure to antigen)  under the influence of the 
germinal  center  microenvironment  (7).  Finally,  this  microenvironment  has  been 
implicated as a  site for the generation  of memory B cells  (10,  11); this possibility is 
now being tested using purified PNA  hi cells in adoptive transfer experiments. 
The present  studies  extend  our examination  of GCLC to another aspect  of their 
differentiative state--their migratory capability. The vast majority of mature periph- 
eral  lymphocytes migrate continuously between  various lymphoid organs,  traveling 
from the lymph into the systemic vasculature, then leaving the bloodstream to reenter 
lymphoid tissues (13).  This recirculation  pattern  presumably allows the whole spec- 
trum  of  lymphocytes  with  predetermined  specificities  to  encounter  and  react  to 
localized  antigen  deposits.  The  traffic  of lymphocyte  populations  can  be  directed 
preferentially through  either mucosal or nonmucosal  lymphoid organs by virtue of 
selective  recognition  of  organ-specific  determinants  on  high  endothelial  venules 
(HEV),  the  specialized  vessels  in  lymphoid  organs  that  serve  as  major  sites  of 
lymphocyte emigration from the blood  (14,  15). If PP GCLC are precursors of IgA 
plasma cells,  as their expression of surface IgA seems to suggest  (1,  16), then it might 
reasonably be expected that they would be preprogrammed to migrate selectively to 
mucosal-associated tissues (i.e., sites of IgA secretion). Such selective migration might 
be directed by the expression of recognition receptors for organ-specific determinants 
associated  with  endothelial  cells  in  mucosal  tissues,  as  proposed  for  gut-homing 
mesenteric  node  and  thoracic  duct  immunoblasts  (14,  17). On  the  other  hand,  a 
variety of experiments  have  indicated  that  "germinal  center  cells  stand  as  islands 
amidst  the  general  flow and  traffic of migrating  cells"  (18).  Although  GCLC  and 
certain  immunoblasts are thought  to be capable of entering germinal centers when 
applied locally (19, 20), cellular exchange between germinal centers and the surround- 
ing pool oflymphocytes is in general remarkably difficult to detect (18). This apparent 
segregation  of  germinal  centers  suggests  that  GCLC  may  not  be  competent  to 
recirculate, and may in  fact lack the normal migratory mechanisms that most small 
lymphocytes possess. 
The studies  reported  here support  the  view that  germinal  centers  harbor B  cells 
undergoing a  nonmigratory stage of antigen-activated  differentiation.  Our  findings 
indicate  that  GCLC  are  unable  to  migrate  normally  into  lymphoid  tissues,  and 
suggest that this migratory deficiency is due in large part to their inability to recognize 
and bind to the post-capillary HEV that normally mediate the passage ofrecirculating 
blood lymphocytes into lymphoid organs. 
Materials and Methods 
Animals.  2-3-mo-old BALB/c and BALB.K (H-2 k) mice were bred and maintained in our 
colony. 
Preparation of Cell Suspensions.  Cell handling procedures and cell suspending medium (CSM) 
have been described  (15, 21). 
Enrichment for GCLC by Panning.  GCLC, which  comprise up to 20-30% of the lymphocytes 
in PP (1, 6), were isolated  from suspensions of PP lymphocytes (PPL)  by taking advantage of 
their unique IgD-, PNA  hi phenotype. A two-stage  "panning" (22) procedure was used. First, 
petri dishes  (100 ×  15 ram,  1029; Falcon Labware, Oxnard, CA) were coated with a mouse 
monoclonal  antibody  directed  against  IgD  (anti-Igh-5a,  clone  H10-4-22  [23], purified  by 
adsorption and elution from a protein A-Sepharose  column)  at 50 p.g/ml in 0.15 M NaCI, 0.05 
M Tris-HCl, pH 9.5.3 ×  107 PPL per plate were incubated at 4°C for 40 rain, after which  the 
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cells  (predominantly T  cells  and  GCLC)  were  then  recovered  and  positively selected  by 
incubation on dishes coated with PNA (E. Y. Laboratories, San Mateo, CA) at 50 #g/ml. The 
plates were  decanted and washed  gently, and the  bound PNA  hi cells  were  then eluted by 
incubating the dishes  for  15  min at  room temperature with 0.2  M  galactose in phosphate- 
buffered saline (PBS) containing 2% newborn calf serum. A pasteur pipette was used to squirt 
the plates vigorously to further release  the adherent cells. Finally, the purified cells  (90-95% 
PNA  hi, 90-100% viable) were washed through serum and resuspended in CSM. Roughly 2 × 
10  6 purified GCLC were recovered per plate, representing a 25-35% recovery of PNA  cells. 
Suspension Staining for Identification of GCLC lgD + B  Cells, and  T  Cells.  Using techniques 
described previously (15), cell suspensions were analyzed by fluorescence microscopy to detect 
surface markers characteristic of different lymphocyte subpopulations. Fluoresceinated PNA 
(fluorescein isothiocyanate (FITC)-PNA) (E. Y. Laboratories) was used as a marker for GCLC, 
while IgD  + B cells were  detected using purified, biotinylated H10-4-22  (see above) as a  first 
stage,  followed  by an FITC-avidin second stage (Vector Laboratories, Inc., Burlingame, CA). 
T  cell reagents included first stage monoclonal rat antibodies directed against Thy-l.2 (clone 
30-H12)  and Lyt-1  (clone 53-7.3) (24), followed by an affinity-purified, highly specific fluores- 
ceinated rabbit anti-rat Ig second stage.  For simultaneous staining of T  cells and IgD  + B cells 
(a procedure that identifies GCLC by their lack of fluorescence),  anti-IgD, anti-Thy-l.2, and 
anti-Lyt-1 reagents were simply mixed together. 
Tissue Section Staining.  Brachial lymph nodes were removed 7 d after front footpad immu- 
nization with 1-2 ×  10  7 sheep erythrocytes. Frozen sections of these antigen-stimulated lymph 
nodes and of PP were air-dried for 5 min, fixed in cold acetone for 2 min, and then incubated 
successively  with  (a)  150 #g/ml  MEL-14,  a  rat  monoclonal antibody directed  against  the 
putative lymphocyte receptor for peripheral node HEV (25), (b) a second stage rabbit anti-rat 
Ig at  200 #g/ml, and  (c)  a  third stage horseradish peroxidase-coupled swine anti-rabbit Ig 
antiserum (Dako Corp., Santa Barbara, CA; used at 1:2). IgD  + B cells and/or germinal centers 
were defined in serial sections using biotinylated anti-IgD (H10-4-22)  and biotin-conjugated 
PNA (E. Y. Laboratories), respectively, followed  by horseradish peroxidase-conjugated avidin 
(Vector Laboratories, Inc.) as a second stage.  Incubations and development of staining with 
substrate were carried out as described elsewhere  (1). 
Direct Fluorescent Labeling of Cells.  Using methods reported previously (15), lymphocytes were 
labeled with FITC or tetramethylrhodamine isothiocyanate (TRITC) under conditions which 
produced intense cellular fluorescence  without altering cell  viability, migratory capacity, or 
detectability of ceil surface antigens. 
In Vivo Homing Studies 
Two different protocols were used to study the localization of GCLC in vivo: 
HOMING  STUDIES  USING  51CR-LABELED  LYMPHOCYTES.  Sample  populations  (PNA hi  PPL, 
PNA  1°  PPL,  unseparated  PPL,  or  mesenteric node  l~mphocytes  [MNL])  were  labeled by 
incubation  for 1 h at 37°C in 100 #Ci Na SICrO4/2 x  10  ceUs/ml CSM. After washing through 
a large cushion of serum, labeled cells from each sample population (2-5 X  106 cells carrying 
20,000-35,000 cpm) were injected intravenously into each of two to three syngeneic recipients. 
Radioactivity in recipient organs was determined 2 h  later. The following host organs were 
removed  and  analyzed:  pooled  lymph  nodes  (axillary, brachial,  inguinal, and  mesenteric 
nodes), PP,  small intestine, spleen, lung, and liver.  Results are expressed  as  the  percent of 
injected cpm retained by an organ: [(organ count -  background)/(total counts injected)] X 
100. 
HOMING STUDIES  USING TRITC-LABELED  LYMPHOCYTES.  2  ×  107 TRITC-labeled unseparated 
PPL or antigen-stimulated peripheral node lymphocytes (PNL)  were injected intravenously 
into syngeneic recipients. 2 and 24 h later, separate cell suspensions were made from recipient 
lymphoid organs (peripheral lymph nodes, PP, mesenteric node, spleen, and bone marrow). 
Aliquots of these suspensions were counterstained with fluoresceinated reagents to determine 
the proportions of GCLC and other lymphocyte subpopulations among the localized rhoda- 
minated sample cells.  These  proportions were  then  compared  with  the  proportion  of the 
corresponding lymphocyte subpopulation in the injected sample population. 
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Stamper and Woodruff (26), has been described previously in detail (21). Briefly, lymphocytes 
in Hanks' balanced salt solution containing 1~7~ bovine serum albumin were  incubated with 
mild agitation for 30 min at  7°C on freshly  cut frozen  sections of lymph nodes or PP. After 
incubation,  adherent cells were fixed to the sections by placing the slides in cold PBS containing 
1% glutaraldehyde. After fixation, the nonadherent cells were gently rinsed off. 
Two  variations of  this  in  vitro  assay  were  performed  to  determine  the  HEV-binding 
properties ofGCLC: (a) Unseparated PPL were incubated on PP and peripheral node sections. 
The proportion of PNA  hi and PNA  l° cells bound to  HEV was  then determined by directly 
staining the  sections  and  adherent  cells  with  FITC-PNA. As  described  elsewhere  (15, 21), 
thinner sections  (6 instead of 10/zm)  and a  milder fixing procedure were  used to minimize 
autofiuorescence and to render PNA  hi and PNA  I° ceils easily distinguishable  from one another. 
(b)  PNA  hi and PNA  l° PPL,  fractionated by panning as  described above, were  incubated on 
separate  sets  of frozen  sections.  To  allow  quantitative comparisons,  an  internal standard 
population of FITC-labeled MNL was mixed in roughly equal proportion with each sample 
population before incubation. The ratio of viable sample to standard cells (RI) was determined 
by fluorescence-activated cell sorter (B-D FACS Systems,  Becton, Dickinson & Co., Sunnyvale, 
CA) analysis as previously described (21). Following incubation, the ratio of sample to standard 
cells  bound to  HEV  (RnEv)  was  determined. Data  were  pooled  from  multiple sections.  A 
specific  adherence ratio (SAR)  was calculated for each sample (SAR  =  RHEv/RI).  To allow 
direct comparisons between sample populations, the HEV adherence of the PNA  hi and PNA  l° 
PPL was related via a  relative adherence ratio (RAR)  to the HEV adherence of a reference 
population of unseparated PPL that had been incubated on a separate set of sections in each 
experiment.  For  example,  the  RAR  (of PNA  hi  to  unseparated  PPL)  equals SARpNAhippL/ 
SAR ....  parated PPL. The RAR is equivalent to the calculated number of sample cells bound to 
HEV per reference cell bound under the same conditions. 
Fluorescence Microscopy.  A Zeiss microscope equipped with HBO .50 W mercury vapor lamp 
epi-illumination  and exciter/barrier filter combinations for rhodamine (546 nm excitation) and 
fluorescein  (440 490 nm excitation) was used. 
Statistical analyses.  Calculation of standard errors  of cell suspension counting data (e.g., the 
proportion  of  PNA  hi  cells  in  unseparated  PPL)  was  based  on  the  binomial distribution. 
Standard errors of ratios (e.g., RAR) were calculated using the delta method (27). 
Results 
In  Vivo Localization  of GCLC after Intravenous Injection.  For technical reasons, we have 
chosen to focus our attention primarily on the migratory properties of PP rather than 
peripheral node GCLC. Due to the continuous exposure of PP to a variety of intestinal 
antigens, germinal centers can regularly be found in this site, with GCLC comprising 
10-30% of the lymphocyte population (I, 6). Furthermore, GCLC can be confidently 
identified in PP cell suspensions solely on the basis of their PNA  hi phenotype, whereas 
PNA must be used in conjunction with other markers to  identify GCLC  in lymph 
nodes and spleen because these organs contain a significant number of PNA  hi T  cells 
(7). 
As shown in Table I, ~lCr-labeled PNA  hi PPL home very poorly to lymph nodes, 
PP,  and the spleen in comparison with  PNA  1° PPL,  unseparated PPL,  and MNL. 
The small amounts of radioactivity that were detected in the lymph nodes and PP of 
PNA  hi PPL recipients could be explained by the expected localization pattern of the 
10% T  cell and IgD  + B cell contaminants in the panned PNA  hi fraction. PNA  hi PPL 
also  migrate  to  the  gut  wall  in  very  small  numbers, as  do  the  small  lymphocyte 
populations studied, whereas other investigators have shown that many immunoblasts 
from the thoracic duct lymph and mesenteric node home rapidly and specifically to 
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TABLE  I 
In  Vivo Localization Pattern of51Cr-labeled PNA ni PPL (GCLC) in Comparison with other Lymphocyte 
Populations * 
Recipient organ 
Mean percent of injected cpm localized ±  SE:~ after injection of 
PNA  hi PPL  PNA  l° PPL  Unseparated  MNL 
PPL 
Lymph nodes§  0.23 ±  0.03  2.8 ±  0.4  2.1  +  0.3  7.0 +  0.9 
PP  0.17±0.02  l.l -1-0.2  1.1 ±0.2  2.3+0.3 
Small intestine¶  0.32 ±  0.04  0.33 ±  0.05  0.54 +  0.08  0.54 +  0.08 
Spleen  8.7 +  1.1  19 :tz 2.9  18 +_ 2.7  31 ±  3.9 
Lung  7.1 ±  0.9  5.3 +  0.8  5.3 +  0.8  2.1  ±  0.3 
Liver  32 +- 4.1  21 +  3.3  19 ±  3.0  17 ±  2.2 
Number of recipients  3  2  2  3 
Cpm injected per recipient  32,400  20,300  34,700  33,400 
* 51Cr-labeled lymphocytes were injected intravenously into syngeneic recipients, and the radioactivity in 
recipient  organs was determined  2  h  later.  Sample  populations  included  (a)  PNA  hl  PPL  (90  ±  1.3% 
PNA  hi) purified using the two-stage panning procedure described in Material and Methods, (b) unsepa- 
rated  PPL  (18  ±  1.7%  PNAhi), and  (c)  MNL.  PNA  l° PPL,  recovered by decanting the unbound PPL 
fraction after panning with PNA alone, were included primarily as a control for cell handling. Removal 
of PNA  hi cells was incomplete, with the PNA  I° fraction still containing 6 +  1.0% PNA  hi cells. 
:~ Standard  error  =  ~7 (0.221/~n),  where ~  is the mean percent  of injected cpm localized  in a  recipient 
organ, n is the number of recipients, and 0.221  is the result of an analysis of variance performed on log- 
transformed data. 
§ Pooled axillary, brachial, inguinal, and mesenteric lymph nodes. 
¶ After removal of PP. 
TABLE  II 
PPL Localizing  in Lymphoid  Tissues are Predominantly Non-GCLC* 
Phenotype of localized donor PPL 
Percent Thy- 
Recipient Organ  Percent PNAhi~k  Percent IgD+§  1.2  +, Lyt-I +, or 
IgD+§ 
2 h  24 h  24 h  24 h 
Peripheral lymph nodes¶  0.0 (<0.7)  0.0 (<0.7)  45 (2.2)  99 (0.4) 
PP  0.0 (<0.7)  0.0 (<0.7)  88 (1.4)  99 (0.5) 
Mesenteric lymph nodes  0.0 (<0.7)  0.0 (<0.7)  65 (2.1)  99 (0.5) 
Spleen  1.0 (<2.3)  0.8 (<2.0)  68 (2.1)  98 (0.6) 
Bone marrow  1.6 (<3.1)  1.2 (<2.6)  70 (2.1)  94 (1.3) 
* 2 ×  10  7 unseparated TRITC-labeled PPL  (17  -4-  1.7% PNA  hi, 45 +  2.2% IgD  ÷, and 76 +  1.9% staining 
with  anti-Thy-l.2, anti-Lyt-1, and anti-IgD combined)  were  injected  intravenously into  each  of four 
syngeneic recipients.  At  both  2  and  24  h  after  injection,  cell  suspensions were  prepared  from similar 
organs pooled from two recipients. The cells were counterstained with anti-IgD, anti-IgD plus anti-T cell, 
and/or fluorescein-indicated PNA reagents. For each organ and staining condition, 500 localizing donor 
lymphocytes were detected as red cells under a  fluorescence microscope, and were assessed for staining 
with the fluoresceinated reagents by switching filter sets to visualize green fluorescence. 
:~ Upper limits of 95% confidence intervals are given in parentheses. 
§ Standard errors are given in parentheses. 
¶ Unless otherwise indicated,  "peripheral  lymph nodes" refers to pooled  axillary, brachial, and inguinal 
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of GCLC  may  be  their  preferential  entrapment  by  the  liver;  many  PNA  hi  PPL 
localized in this organ despite the fact that these cells were >95% viable when injected. 
One potential  problem  in  interpreting  these  results  is  that  the  PNA  hi cells  could 
have suffered some damage or alteration  by being bound to the PNA-coated plates, 
thereby rendering them migratory incompetent and increasing their susceptibility to 
sequestration by the liver.  However, confirmatory results were obtained in a comple- 
mentary experiment in which unseparated TRITC-labeled PPL were injected intra- 
venously into syngeneic recipients, with  the surface phenotype of the localizing cells 
determined 2 and 24 h later (Table II). 17% of the injected PPL were PNA  hi, whereas 
none of the cells localizing in PP or lymph nodes, and only 1% of the TRITC-labeled 
cells  found in the spleen bound high levels  of PNA (500  localized cells were counted 
from each organ).  It is possible that  the GCLC actually were homing to lymphoid 
organs in these experiments,  but were rapidly losing or masking their PNA-binding 
sites  in vivo and therefore were not detected when counterstained.  Since GCLC can 
also be  identified  as  IgD- B cells  (1), this  possibility was tested  by counterstaining 
aliquots from recipient organ cell suspensions simultaneously with anti-IgD and anti- 
T  cell  (Thy-l.2 and  Lyt-1) monoclonal antibodies,  thus  identifying GCLC by their 
lack of green fluorescence. 98-99% of the TRITC-labeled lymphocytes that localized 
in  lymph nodes,  PP,  and  spleen  were stained  by this  procedure,  indicating that  T 
cells  and  IgD  +  B  cells,  but  not  GCLC,  were  migrating  to  these  sites.  In  another 
experiment, GCLC in antigen-stimulated peripheral nodes exhibited a similar inabil- 
ity to home:  2  h  after  injection  of PNL containing  13%  PNA  hi  B  cells,  few  if any 
GCLC  localized  in  HEV-bearing  organs.  In  peripheral  lymph  nodes,  only  3/700 
localized cells  scored were PNA  hl , whereas 495/500 stained with anti-T cell or anti- 
IgD reagents. In recipient PP, 0/600 were PNA  hi, and 497/500 stained with anti-IgD 
or T  cell antibodies. 
HEV-binding Ability of GCLC.  The migratory insufficiency of GCLC could be due 
either  (a)  solely to the entrapment  of these cells  in  the  liver or other organs before 
they have an opportunity to migrate into lymphoid sites, or (b) to a lack of functional 
homing receptors,  as  might  be evidenced by the  diminished  capacity of these  lym- 
phocytes to recognize and to adhere to the HEV which normally direct lymphocyte 
exit from the bloodstream. We tested the ability of GCLC to bind in vitro to HEV in 
frozen sections  of PP  and  lymph  nodes.  In  an  experiment  examining  the  in  vitro 
binding of a  PPL population containing  19% PNA  hi cells,  only 2/500 cells  adhering 
to  PP  HEV,  and  1/500  cells  bound  to  peripheral  node  HEV,  were  PNA  hi.  In  a 
complementary experiment, purified GCLC were shown to bind to HEV only 10% as 
well  as unseparated  PPL, a  level  of binding that could be caused by residual T  cell 
and IgD  ÷ B cell contaminants. These results are presented in Table III. This in vitro 
analysis demonstrates that GCLC fail  to recognize and bind to HEV, and thus lack 
an ability that appears strictly necessary for normal lymphocyte migration. 
GCLC Fail to  Express the  Putative Homing Receptor Determinant Recognized by  MEL- 
14.  The failure of GCLC to adhere to peripheral node HEV might be explained at 
the biochemical level by their lack of expression of a surface "receptor" for peripheral 
node  endothelial  cells.  Evidence supporting such  a  lack  of receptor expression  has 
been  obtained using MEL-14, a  monoclonal antibody that  recognizes a  cell surface 
determinant that either is closely and universally associated with, or is in fact on the 
lymphocyte receptor  for  peripheral  node  HEV  (25).  Immunohistologic studies  of R.  A.  REICHERT,  W.  M.  GALLATIN,  I.  L.  WEISSMAN, AnD E.  C.  BUTCHER  819 
TABLE III 
GCLC Fail to Bind to HEV 
Relative binding to HEV (RAR)* 
Organ 
section  Counterstained  Purified  Unseparated 
PNA  hi PPL~:  PNA  hl PPL§  PNA  l° PPL¶  PPL 
Peripheral  0.0  (<0.06)  0.1  (0.02)  0.9  (0.1)  Unity 
lymph nodes 
PP  0,0  (<0,07)  0.1  (0.02)  0.8 (0.1)  Unity 
* RAR  is  the  calculated  number of sample  cells  that  would  bind  to  HEV  per 
unseparated PPL binding if an equal number of  each were incubated on the sections 
under the same conditions. 
:~ After incubation of unseparated PPL on the sections, PNA  hl cells were detected by 
counterstaining HEV-adherent PPL with FITC-PNA. 19 -t- 1.8% of the unseparated 
PPL were PNA  hl. Upper 95% confidence limits are in parentheses. 
§ These cells  were purified using the two-stage panning procedure, and were 94  + 
1.2% PNA  hi. Standard errors are in parentheses. 
¶ Nonadherent  PPL  recovered  from  PNA-coated  plates  (10  +  1.4% PNA  hi)  were 
included as a control for cell handling. Standard errors are in parentheses. 
frozen sections of PP (Fig.  1) and antigen-stimulated peripheral nodes (Fig. 2) reveal 
that  the vast majority of GCLC  (PNA  m lymphocytes) are MEL-14-, whereas  most 
other B  and T  cells in these sites are MEL-14  +.  In Fig.  2 B, note that  virtually the 
only cells in  stimulated  nodes  which  fail to stain  with  MEL-14 besides  GCLC are 
those that reside within medullary areas. The nonstaining of these zones might have 
been predicted, since medullary areas consist predominantly of a  delicate meshwork 
of resident  plasma cells  and  reticular  cells,  and  not  of unstimulated,  recirculating 
lymphocytes. 
Discussion 
We  have  demonstrated  that  GCLC  home  very  poorly  to  lymphoid  tissues  in 
comparison  with  other  lymphocyte  populations.  The  principal  features  of  these 
lymphoblasts that may render them migratory incompetent are (a)  their inability to 
recognize and bind to HEV, which  almost certainly precludes  their migration  into 
lymphoid tissues via the bloodstream, and (b) their possession of high levels of surface- 
binding  sites  for  PNA--presumably  terminal  galactosyl residues  (29)--which  may 
make them susceptible to sequestration by the liver. These characteristic features of 
GCLC merit further discussion. 
A likely explanation for the failure of GCLC to adhere to HEV when incubated on 
either PP or peripheral node sections is simply that these cells may lack the surface 
molecules necessary for lymphocyte-endothelial cell recognition. In fact, both PP and 
peripheral node GCLC fail to express detectable levels of the cell surface determinant 
recognized  by MEL-14,  a  determinant  that  is  on  or  near  the  lymphocyte surface 
receptor  for peripheral  node  endothelial  cells.  An  in-depth  characterization  of the 
distribution  and  the  nature  of the  determinant(s)  recognized  by  MEL-14  will  be 
presented in a subsequent manuscript. 2 
We must reconcile the nonmigratory nature of GCLC with the concept that these 
lymphoblasts must eventually leave the germinal center microenvironment in order 
2 W. M. Gallatin, I. L. Weissman, and E. C. Butcher~  A cell surface molecule involved in organ-specific 
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Fro.  1.  Immunoperoxidase analysis of the cellular distribution of the putative receptor for periph- 
eral node ttEV in nmrine PP.  A and B are serial  frozen sections ofa PP as it is found in situ in the 
wall of the small intestine, with A stained with PNA to define germinal centers, and B stained with 
MEL-14,  a  monoclonal antibody directed  against  a  determinant  associated with  the lymphocyte 
hi  receptor for peripheral node HEV (see text).  The figure illustrates that PNA  lymphocytes (GCLC) 
and MEL-14-staining cells are largely mutually exclusive populations. Fro.  2.  Additional  immunoperoxidase studies using serial sections of a  sheep erythrocyte-stimu- 
lated  brachial  lymph node.  The section  in  panel A  has been stained with PNA and  has several 
PNA  hi germinal centers. MEL-14 staining of the section in panel B reemphasizes that most GCLC 
fail to express the determinant recognized by MEL-I4 (also note the nonstaining medullary area-- 
see text). C  illustrates the distribution of cells bearing surface IgD, and is included to demonstrate 
that  GCLC  are  IgD-,  and  to  define  IgD  +  B  cell  domains  and  the  nonstaining T  cell  areas. 
Comparison of B and C confirms that MEL-14 stains the vast majority of T  cells and IgD  + B cells 
in antigen-stimulated lymph nodes. 
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to fulfill their putative effector functions as memory B cells and/or plasma cells.  For 
example,  circumstantial  but  fairly  convincing  evidence suggests  that  PP  germinal 
centers harbor precursors of the IgA-secreting plasma cells that populate the lamina 
propria of the gut and other mucosal sites. PPL generate IgA-containing cells in the 
spleen and lamina propria of adoptive transfer recipients (30-32) and yield cells that 
possess cytoplasmic IgA when stimulated in vitro by pokeweed mitogen (33).  Studies 
in  rabbits  have shown  that  the  precursors  of these  cells  are  a  surface  IgA  +,  IgM- 
subpopulation of PPL  (8).  Because most surface IgA  + cells (70-85%)  and almost all 
IgM- B  ceils in  mouse PP are GCLC  (t),  IgA plasma cell  precursors are probably 
largely contained in the germinal center B cell population. While in PP these plasma 
cell precursors (GCLC or otherwise) contain little or no cytoplasmic Ig (16),  and take 
up to 7-14 d to generate IgA plasma cells in adoptive transfer recipients (30,  32).  The 
lag time for plasma cell generation suggests that these precursor cells require a period 
of further differentiation, perhaps in the host's mesenteric lymph node or spleen  (16, 
32).  By contrast,  IgA plasma cell precursors found  in mesenteric node and thoracic 
duct lymph exhibit more advanced characteristics: Many of these surface IgA  +, IgM- 
immunoblasts, thought  to be derived from the PP precursors, possess cytoplasmic as 
well  as  surface  IgA  (16),  and  are  capable of migrating  rapidly  and  specifically to 
mucosal  sites  where  they can  differentiate  into  plasma cells  as  early as  24  h  after 
transfer (16,  31). 
In light of these observations, the inability of GCLC to recognize HEV is viewed as 
a transient phenomenon related to a specific phase of B cell differentiation that occurs 
within  the confines of the germinal center microenvironment.  We propose that  PP 
GCLC eventually migrate out of the germinal center and, at  that  time or during a 
subsequent  period  of  maturation,  reexpress  organ  or  tissue-specific  receptors  for 
endothelial cells in mucosal-associated tissues. These newly acquired homing receptors 
would then selectively direct the migration of these cells to mucosal sites, where they 
would  differentiate into  IgA-secreting plasma cells,  thereby accounting  for the ob- 
served limitation of IgA-secreting cells to these areas. It is possible that the migration 
of lymphocytes to the gut wall is initially directed  by lymphocyte recognition of an 
endothelial  determinant  similar to  (or perhaps  the  same as)  that  expressed on  PP 
HEV  (14,  17). Consistent  with  this  hypothesis,  many gut-homing mesenteric  node 
immunoblasts do in  fact express receptors specific for PP  HEV  (14,  17). Adoptive- 
transfer experiments with purified populations of PP GCLC are now in progress, and 
should  provide more insight  into  the origin  of the  mucosal  IgA response. Although 
less well characterized, some IgG plasma cell precursors are thought to reside within 
peripheral node germinal centers  (7,  10,  11), where we would expect similar consid- 
erations  to  apply  (e.g.,  eventual  induction  of organ  or  tissue-specific  recognition 
mechanisms leading to the distribution of IgG plasma cells to nonmucosal lymphoid 
organs and tissues). 
The transient nonmigratory phase of differentiation undergone by GCLC may be 
a general feature of antigen-activated lymphocytes. Earlier investigations have shown 
that  lymphocytes capable  of recognizing  an  immunizing  antigen  are  functionally 
absent  from the recirculating lymphocyte pool for  1-2 d  after intravenous adminis- 
tration  of  that  antigen  (34,  35).  Antigen-reactive  cells  gradually  return  to  the 
circulation as dividing, activated lymphocytes after a period of local proliferation in 
lymphoid tissues (34,  35). Thus, antigen-activated lymphocytes may require a phase R. A.  REICHERT, W.  M.  GALLATIN, I. L. WEISSMAN, AND E. C.  BUTCttER  823 
of local proliferation and differentiation, whether in germinal centers or other sites of 
blastogenesis, during which alterations of their migratory capabilities and/or specific- 
ities may occur. 
One  of the  most  characteristic  and  perhaps  functionally  significant  features  of 
GCLC is their expression of high levels of PNA-binding sites. These sites, thought to 
be  terminal  galactosyl  residues  (29),  are  normally  masked  by  sialic  acids  on  the 
majority of circulating lymphocytes (36),  thus  presumably providing the molecular 
basis  for  the  distinction  between  PNA  hi  and  PNA  l°  lymphocytes.  Neuraminidase 
treatment of glycoproteins or lymphocytes removes terminal sialic acids and reveals 
the normally subterminal galactosyl residues. Several investigators have demonstrated 
that these desialylated glycoproteins (37) and lymphocytes (36, 38) are rapidly cleared 
from the circulation due to sequestration in the liver. Neuraminidase-treated lympho- 
cytes can be released after resynthesizing cell surface carbohydrates, which indicates 
that the liver is not scavenging these cells simply because of nonspecific damage (38). 
The enzymatically altered lymphocytes can still recognize HEV  (39),  implying that 
their  hepatic  entrapment  is  not  caused  by  an  impairment  of  the  cells'  normal 
migratory mechanisms. Rather, the presence of galactose-specific, lectin-like molecules 
on the surfaces of hepatocytes (40, 41) and/or Kupffer cells (42, 43) may mediate the 
localization of these cells in the liver. In support of this suggestion, both rat hepatocytes 
and  Kupffer cells  have  been  shown  to  spontaneously  aggregate  with  desialylated 
lymphocytes and erythrocytes (42).  This in  vitro rosette formation can be inhibited 
by the addition of galactose, which suggests that the cell-cell interaction is mediated 
by  the  terminal  galactosyl  residues  of  the  desialylated  cells  (42).  Whatever  the 
mechanism,  the  hepatic  clearance  of  desialylated  cells  may  also  function  in  the 
trapping of naturally  occurring  PNA  hi  lymphocytes (e.g.,  GCLC  and  cortical  thy- 
mocytes), since these cells also have abundant  terminal  galactosyl residues. It seems 
likely that  Kupffer cells, which are in direct contact with the sinusoidal  blood, may 
play more of a role in the entrapment of desialylated ceils than hepatocytes, since the 
fenestrated endothelium lining the sinusoids of the liver serves as a functional barrier 
between hepatocytes and blood-borne cells. 
The  presence of endogenous,  galactose-specific molecules on  liver cells  makes  it 
tempting to speculate that  lectin-like molecules with similar specificity may also be 
present on stromal elements in germinal centers and the thymic cortex, where they 
could  retain  PNA  hi  cells  at  particular  stages  of differentiation.  Such  a  model  of 
lymphocyte retention may provide a  specific recognition mechanism to help explain 
reports that certain blasts in the lymph of stimulated lymph nodes are able to migrate 
into germinal centers when applied locally to the next node in a  lymph node chain 
(19),  and  that  rabbit  appendix  cells  contain  a  population  of blasts  (presumably 
GCLC) that are able to enter spleen germinal centers following intravenous injection 
(20). These reports of blasts migrating into germinal centers should not be interpreted 
as contradictory to our results,  because  (a)  the autoradiographic  techniques used in 
these experiments could detect the localization of a minor lymphocyte subpopulation 
that would be quantitatively insignificant in our assays, (b) local application of blast 
cells bypasses HEV and therefore does not address the problem of blast cell migration 
from blood into HEV°bearing lymphoid organs, and  (c) we have indeed  found that 
a small proportion of GCLC localize in the spleen. 
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tory  behavior  has  led  us  to  speculate  further  on  the  significance  of  lymphocyte 
expression of PNA-binding sites.  It has been suggested that  PNA binding may be a 
marker for immature cell types (44,  45).  However, our phenotypic analysis suggests 
that  PNA  hi  PPL are  fairly well-developed lymphocytes, (the  majority of these cells 
express surface IgA, an isotype not expressed until relatively late in B cell differentia- 
tion  [1]).  We  suggest  instead  that  PNA  may  serve  as  a  marker  for  nonmigratory 
lymphocytes  proliferating  and/or  differentiating  under  local  microenvironmental 
influences.  The major PNA  hi  lymphocyte populations  (GCLC,  cortical  thymocytes 
[45],  and possibly a  subpopulation of bone marrow cells [46])  are all geographically 
restricted, rapidly differentiating lymphocytes. Because lymphocytes can resynthesize 
and  modify cell  surface  glycoproteins, a  probable step  in  switching  from a  sessile, 
migratory-incompetent cell  to  a  circulating,  migratory-competent cell  may involve 
not only the acquisition of receptors for HEV, but also the masking of PNA-binding 
sites by the attachment of sialic acids. Galactosyl residues would no longer be exposed, 
thereby providing "exit visas" for these cells and allowing them to migrate free from 
possible entrapment in the liver by the galactose-specific receptors. Studies are now in 
progress to determine the extent of correlation between migratory incompetence and 
lymphocyte expression of high levels of PNA-binding sites. 
Summary 
Germinal  center  B  cells  (GCLC)  are  a  discrete  population  of antigen-activated 
lymphoblasts that lack surface IgD and express abundant cell surface binding sites for 
peanut agglutinin  (PNA). These phenotypic features render GCLC easily distinguish- 
able from nearly all plasma cells, T  cells, and unstimulated B cells, and have enabled 
us to identify and  isolate GCLC from antigen-stimulated  murine lymphoid organs. 
We have examined the migratory properties of these lymphoblasts in  (a)  short-term 
in  vivo homing studies,  and  (b)  an  in  vitro assay  of lymphocyte binding  to  post- 
capillary, high endothelial  venules  (HEV)  in  frozen sections of Peyer's patches and 
peripheral  lymph nodes.  In  the  in  vivo experiments,  intravenously  injected  GCLC 
failed to migrate in significant numbers to peripheral lymphoid organs in comparison 
with T  cells or IgD  ÷ B cells.  In the in vitro binding assay, GCLC did not adhere to 
HEV in either Peyer's patch or peripheral node sections. A variety of factors, such as 
preferential sequestration in the liver, may operate in vivo to influence the localization 
of these cells.  However, their nearly total failure to migrate into lymphoid organs can 
best be explained by their inability to recognize and adhere to the specialized HEV 
which normally mediate the emigration of recirculating lymphocytes from the blood 
into these sites. The concept that GCLC fail to express functional  homing receptors 
for HEV has been further supported by studies using MEL-14, a monoclonal antibody 
that appears to recognize the lymphocyte surface receptor for peripheral node HEV: 
In  contrast  to  most  peripheral  lymphocytes,  GCLC  fail  to  bind  MEL-14.  These 
migratory  and  endothelial-recognition  properties  of GCLC,  when  viewed  in  the 
context of the possible role of these cells as precursors of plasma cells and/or memory 
B cells, have led us to propose that the inability of GCLC to recognize HEV may be 
transient and related to a phase of sessile B cell differentiation. 
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